| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/21/1999 | EP0859635B1 Stabilised pharmaceutical compositions containing dobutamine |
| 04/21/1999 | EP0748208B1 Cosmetic and/or pharmaceutical preparations |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | CN1214686A Derivatives of camptothecin for use in treating cancer |
| 04/21/1999 | CN1214633A Stabilised growth hormone formulation and method of preparation thereof |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214348A Bivalent reaction water-soluble high molecular derivative and complex including the same |
| 04/21/1999 | CN1214264A Sulfanilamide derivative for diagnosis and treatment of tumor and its preparation |
| 04/21/1999 | CN1214211A Anti-senility cancer-preventing health beverage |
| 04/20/1999 | US5895757 Encapsulation of living tissue cells in inorganic microspheres prepared from an organosilicon |
| 04/20/1999 | US5895663 Pseudoephedrine hydrochloride extended-release tablets |
| 04/20/1999 | US5895659 Finely dispersed carotenoid and retinoid suspension and their preparation |
| 04/20/1999 | CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 04/20/1999 | CA2116524C Antiphlogistic analgesic plastic |
| 04/17/1999 | WO1999020257A1 Hormone replacement therapy drug formulations for topical application to the skin |
| 04/15/1999 | WO1999018142A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 04/15/1999 | WO1999018121A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | WO1999018119A1 Process for freeze-drying proteins |
| 04/15/1999 | WO1999017806A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 04/15/1999 | WO1999017804A1 Polymeric derivatives of camptothecins |
| 04/15/1999 | WO1999017783A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | WO1999017780A1 Dexamethasone gel |
| 04/15/1999 | WO1999017771A1 Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine |
| 04/15/1999 | WO1999017766A1 Compressed nitroglycerin tablet and its method of manufacture |
| 04/15/1999 | WO1999017764A1 Medicament containing delta-aminolevulinic acid |
| 04/15/1999 | WO1999017761A1 Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome x |
| 04/15/1999 | WO1999017752A1 Improved dosage units |
| 04/15/1999 | WO1999017750A1 Method for making a multi-stage drug delivery system |
| 04/15/1999 | WO1999017748A1 Taste masked pharmaceutical compositions |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017740A1 Peptide/lipid complex formation by co-lyophilization |
| 04/15/1999 | WO1999017737A1 Suppository composition |
| 04/15/1999 | WO1999008666A3 Pharmaceutical composition comprising an azateroid |
| 04/15/1999 | WO1999007324A3 Conjugates targeted to the interleukin-2 receptor |
| 04/15/1999 | WO1999004821A3 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 04/15/1999 | WO1999002647A3 Cloning vectors for producing adenoviral minimal viruses |
| 04/15/1999 | WO1999000145A9 Antigenic modulation of viral particules |
| 04/15/1999 | WO1998058668A3 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 04/15/1999 | WO1998029110A3 Formulation and method for treating neoplasms by inhalation |
| 04/15/1999 | DE19744811A1 Composition for tumour diagnosis and/or therapy |
| 04/15/1999 | DE19744113A1 Ophthalmological dexamethasone preparation |
| 04/15/1999 | CA2305761A1 Composition for suppositories |
| 04/15/1999 | CA2305620A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | CA2305599A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2303097A1 Polymeric derivatives of camptothecins |
| 04/15/1999 | CA2273275A1 Improved dosage units |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908176A1 Intravenous administration form of thalidomide for the therapy of immunologic diseases |
| 04/14/1999 | EP0908169A2 Composition for use as a wound dressing |
| 04/14/1999 | EP0907664A1 Oxidized oligosaccharides |
| 04/14/1999 | EP0907633A1 New synthetic catechol derivatives, method for production and use thereof |
| 04/14/1999 | EP0907364A1 Pharmaceutical compositions |
| 04/14/1999 | EP0907358A2 Uniform drug delivery therapy |
| 04/14/1999 | EP0907356A1 Aerodynamically light particles for pulmonary drug delivery |
| 04/14/1999 | EP0738252B1 Polyol composition produced by co-spray-drying |
| 04/14/1999 | EP0680320B1 Stable oral ci-981 formulation and process of preparing same |
| 04/14/1999 | EP0605497B2 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln) |
| 04/14/1999 | CN1214078A Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents |
| 04/14/1999 | CN1213972A Contrast agent and improved contrast agent thereof |
| 04/14/1999 | CN1213971A Thermally stabilized contrast agent |
| 04/13/1999 | US5894022 Useful for blockage of vasculature feeding tumors; by cutting blood supply, growth of invasive tumors can be reduced or stopped |
| 04/13/1999 | CA2116799C Solid form xerostomia product |
| 04/13/1999 | CA2068216C Lipospheres for controlled delivery of substances |
| 04/13/1999 | CA1340494C Induction of tolerance to a foreign antigen |
| 04/08/1999 | WO1999017120A1 Preparing conjugates using polyethylene glycol linkers |
| 04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
| 04/08/1999 | WO1999016472A1 Stable compositions containing biologically active components |
| 04/08/1999 | WO1999016470A1 Oral preparation |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016448A1 Sustained-release theophylline tablet |
| 04/08/1999 | WO1999016447A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton |
| 04/08/1999 | WO1999016440A1 Amorphous paroxetine composition |
| 04/08/1999 | WO1999016434A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 04/08/1999 | WO1999016427A1 Active agent transport systems |
| 04/08/1999 | WO1999016423A1 Use of biologically active glass as a drug delivery system |
| 04/08/1999 | WO1999016422A1 Stabilized preparations for use in metered dose inhalers |
| 04/08/1999 | WO1999016421A1 Stabilized bioactive preparations and methods of use |
| 04/08/1999 | WO1999016420A1 Stabilized preparations for use in nebulizers |
| 04/08/1999 | WO1999016419A1 Perforated microparticles and methods of use |
| 04/08/1999 | WO1999016412A2 Non-irritating cosmetic and pharmaceutical compositions |
| 04/08/1999 | WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016313A1 2-methyl-thieno-benzodiazepine formulation |
| 04/08/1999 | WO1999016309A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 04/08/1999 | WO1999003823A3 Novel polyamine analogues as therapeutic and diagnostic agents |
| 04/08/1999 | WO1998056824A3 Incorporation of pharmacologically active amino acid analogues into proteins |
| 04/08/1999 | WO1998055105A9 Fibrinogen-coated microspheres |
| 04/08/1999 | WO1998055103A9 Anti-tumoral therapy agent |
| 04/08/1999 | WO1998035694A9 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
| 04/08/1999 | DE19746805C1 New oxidized starch having high absorption power |
| 04/08/1999 | CA2305681A1 Apoptosis-related compounds and their use |
| 04/08/1999 | CA2305179A1 Oral administration preparation |
| 04/08/1999 | CA2304951A1 Active agent transport systems |
| 04/08/1999 | CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304594A1 Amorphous paroxetine composition |
| 04/08/1999 | CA2273028A1 Stable compositions containing biologically active components |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906325A1 Dendrimers based on saccharides |